143 related articles for article (PubMed ID: 21108695)
1. Telomerase activation without shortening of telomeric 3'-overhang is a poor prognostic factor in human colorectal cancer.
Kojima K; Hiyama E; Otani K; Ohtaki M; Fukuba I; Fukuda E; Sueda T; Hiyama K
Cancer Sci; 2011 Feb; 102(2):330-5. PubMed ID: 21108695
[TBL] [Abstract][Full Text] [Related]
2. Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas.
Butler KS; Hines WC; Heaphy CM; Griffith JK
Cancer Med; 2012 Oct; 1(2):165-75. PubMed ID: 23342266
[TBL] [Abstract][Full Text] [Related]
3. Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing "stemness"-related markers.
Kim H; Yoo JE; Cho JY; Oh BK; Yoon YS; Han HS; Lee HS; Jang JJ; Jeong SH; Kim JW; Park YN
J Hepatol; 2013 Oct; 59(4):746-52. PubMed ID: 23685049
[TBL] [Abstract][Full Text] [Related]
4. TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase.
Xin H; Liu D; Wan M; Safari A; Kim H; Sun W; O'Connor MS; Songyang Z
Nature; 2007 Feb; 445(7127):559-62. PubMed ID: 17237767
[TBL] [Abstract][Full Text] [Related]
5. Abnormal mRNA Expression Levels of Telomere-Binding Proteins Represent Biomarkers in Myelodysplastic Syndromes: A Case-Control Study.
Liu B; Yan R; Zhang J; Wang B; Sun H; Cui X
Turk J Haematol; 2017 Aug; 34(3):200-206. PubMed ID: 28404540
[TBL] [Abstract][Full Text] [Related]
6. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
[TBL] [Abstract][Full Text] [Related]
7. In vivo stoichiometry of shelterin components.
Takai KK; Hooper S; Blackwood S; Gandhi R; de Lange T
J Biol Chem; 2010 Jan; 285(2):1457-67. PubMed ID: 19864690
[TBL] [Abstract][Full Text] [Related]
8. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Haruma K; Chayama K; Yasui W; Tahara E
Int J Oncol; 2001 Sep; 19(3):507-12. PubMed ID: 11494028
[TBL] [Abstract][Full Text] [Related]
9. Expression of TRF1, TRF2, TIN2, TERT, KU70, and BRCA1 proteins is associated with telomere shortening and may contribute to multistage carcinogenesis of gastric cancer.
Hu H; Zhang Y; Zou M; Yang S; Liang XQ
J Cancer Res Clin Oncol; 2010 Sep; 136(9):1407-14. PubMed ID: 20127252
[TBL] [Abstract][Full Text] [Related]
10. Altered mRNA expression of telomere binding proteins (TPP1, POT1, RAP1, TRF1 and TRF2) in ulcerative colitis and Crohn's disease.
Da-Silva N; Arasaradnam R; Getliffe K; Sung E; Oo Y; Nwokolo C
Dig Liver Dis; 2010 Aug; 42(8):544-8. PubMed ID: 20061197
[TBL] [Abstract][Full Text] [Related]
11. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
[TBL] [Abstract][Full Text] [Related]
12. TRF2-tethered TIN2 can mediate telomere protection by TPP1/POT1.
Frescas D; de Lange T
Mol Cell Biol; 2014 Apr; 34(7):1349-62. PubMed ID: 24469404
[TBL] [Abstract][Full Text] [Related]
13. POT1-TPP1 telomere length regulation and disease.
Aramburu T; Plucinsky S; Skordalakes E
Comput Struct Biotechnol J; 2020; 18():1939-1946. PubMed ID: 32774788
[TBL] [Abstract][Full Text] [Related]
14. Expression of telomere binding proteins in gastric cancer and correlation with clinicopathological parameters.
Gao J; Zhang J; Long Y; Lu X
Asia Pac J Clin Oncol; 2011 Dec; 7(4):339-45. PubMed ID: 22151982
[TBL] [Abstract][Full Text] [Related]
15. Clinical Relevance of Telomere Status and Telomerase Activity in Colorectal Cancer.
Fernández-Marcelo T; Sánchez-Pernaute A; Pascua I; De Juan C; Head J; Torres-García AJ; Iniesta P
PLoS One; 2016; 11(2):e0149626. PubMed ID: 26913901
[TBL] [Abstract][Full Text] [Related]
16. Expression of MRE11 complex (MRE11, RAD50, NBS1) and hRap1 and its relation with telomere regulation, telomerase activity in human gastric carcinomas.
Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Kitadai Y; Haruma K; Chayama K; Tahara E; Yasui W
Pathobiology; 2001; 69(4):219-24. PubMed ID: 12007281
[TBL] [Abstract][Full Text] [Related]
17. Telomere profiling: toward glioblastoma personalized medicine.
Ferrandon S; Saultier P; Carras J; Battiston-Montagne P; Alphonse G; Beuve M; Malleval C; Honnorat J; Slatter T; Hung N; Royds J; Rodriguez-Lafrasse C; Poncet D
Mol Neurobiol; 2013 Feb; 47(1):64-76. PubMed ID: 23065374
[TBL] [Abstract][Full Text] [Related]
18. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
19. Changes in the expression of telomere maintenance genes might play a role in the pathogenesis of systemic lupus erythematosus.
Zhou JG; Qing YF; Yang QB; Xie WG; Zhao MC
Lupus; 2011 Jul; 20(8):820-8. PubMed ID: 21693493
[TBL] [Abstract][Full Text] [Related]
20. TRF2 promotes dynamic and stepwise looping of POT1 bound telomeric overhang.
Paul T; Liou W; Cai X; Opresko PL; Myong S
Nucleic Acids Res; 2021 Dec; 49(21):12377-12393. PubMed ID: 34850123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]